Iffmedic Marketing Multiplicom MDx Kits in Central Europe | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Iffmedic will market and sell Multiplicom's molecular diagnostic kits in Central Europe under a deal announced by the companies today.

Under the terms of the deal, the companies will co-promote Multiplicom's products, close sales agreements, and provide support to customers in Germany, Austria, and Eastern Europe. Multiplicom had already been selling its products in Germany.

Financial terms were of the deal not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.